Further processing options
The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?
Saved in:
Journal Title: | Hepatology |
---|---|
Authors and Corporations: | |
In: | Hepatology, 40, 2004, 1, p. 260-263 |
Type of Resource: | E-Article |
Language: | English |
published: |
Ovid Technologies (Wolters Kluwer Health)
|
Subjects: |